about
Natural history of mevalonate kinase deficiency: a literature reviewSystematic reviews in paediatric multiple sclerosis and Creutzfeldt-Jakob disease exemplify shortcomings in methods used to evaluate therapies in rare conditionsUsing inpatient data to estimate the prevalence of Wegener's granulomatosis in China.Estimating epidemiological data of Multiple sclerosis using hospitalized data in Shandong Province, China.Does the low prevalence affect the sample size of interventional clinical trials of rare diseases? An analysis of data from the aggregate analysis of clinicaltrials.gov.The Italian National Rare Diseases RegistryPhenX measures for phenotyping rare genetic conditions.The incidence of inherited porphyrias in Europe.Risk of malignancy associated with head and neck CT in children: a systematic reviewRare thyroid non-neoplastic diseasesCan the EVIDEM Framework Tackle Issues Raised by Evaluating Treatments for Rare Diseases: Analysis of Issues and Policies, and Context-Specific Adaptation.Global Carrier Rates of Rare Inherited Disorders Using Population Exome SequencesA population-based registry as a source of health indicators for rare diseases: the ten-year experience of the Veneto Region's rare diseases registry.Innovative research methods for studying treatments for rare diseases: methodological review.Impact of rare diseases in oral health.Tissue Chips to aid drug development and modeling for rare diseases.Natural history of diseases: Statistical designs and issues.The grand challenge: use of a new approach in developing policies in the area of radiation and health.Symptoms of Autism Spectrum Disorder (ASD) in Individuals with Mucopolysaccharide Disease Type III (Sanfilippo Syndrome): A Systematic Review.Improved Diagnosis and Care for Rare Diseases through Implementation of Precision Public Health Framework.Mortality Statistics and their Contribution to Improving the Knowledge of Rare Diseases Epidemiology: The Example of Hereditary Ataxia in Europe.Real-world Data for Clinical Evidence Generation in Oncology.Towards a therapy for mitochondrial disease: an updateA Nationwide Registry-Based Study on Mortality Due to Rare Congenital Anomalies
P2860
Q26753055-6CE1C47F-0379-4D41-AA88-CC2BF2651501Q28075766-2954D9B6-A13F-414F-822A-26798246AB6DQ31060334-097C9301-8D1E-4667-B8A4-40ED0B86FD7FQ31105435-FC97A858-5FC3-4213-A8E4-EC713DAE77E9Q31169838-4C773D4D-DE29-4F4D-B74E-C77DBDB332EAQ33708908-61A9A13A-D838-4F18-A697-DC289067DED3Q33899022-E4E55F6C-5E3D-4E23-9AF6-A8B2DEE93863Q34309198-1C19DF56-925F-499D-A09A-EFB63BC8EF44Q35211234-612F0E03-A525-4D32-80AF-2524EE66F989Q35530679-95BFF33F-1A31-42AD-BCAE-F87EB97F06F3Q35835153-C89F9939-EABF-46EE-B4B9-B702E9108955Q36027898-C2530357-8FDA-4962-B209-72B931AB8493Q37723828-212E11FA-4156-4B0A-8966-166D161A1904Q38271185-70647905-BC53-46CA-AE69-FA2039AC8FE8Q38913647-C80523B0-13C0-4BEE-9D54-338FE2467659Q38926188-08210E22-5964-4908-A160-8B5FA02AD89AQ39619709-ED615AC5-0AF4-4EDC-812B-96080C83E0F8Q39928814-2E198ADB-9782-4173-9CF1-FE8FE112EFA1Q42373390-08D60896-4DAD-4F84-AF86-97F23386AFE2Q47274350-14DE392E-3068-4FB7-8E5B-03A01CE91F91Q47353377-8F3B7F96-C61F-4197-AC07-3F4E567898D5Q47741869-572BA85B-45AD-43E7-908F-B8336CCCE678Q57293416-88B57CEC-ADF6-4752-93B6-F8C0E1527C40Q58789331-E268CD37-5F6B-403C-A2BE-47681416B681
P2860
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
2010年學術文章
@zh-hant
name
Rare diseases epidemiology research.
@en
Rare diseases epidemiology research.
@nl
type
label
Rare diseases epidemiology research.
@en
Rare diseases epidemiology research.
@nl
prefLabel
Rare diseases epidemiology research.
@en
Rare diseases epidemiology research.
@nl
P2093
P50
P1476
Rare diseases epidemiology research
@en
P2093
Ignacio Abaitua-Borda
Manuel Posada de la Paz
Sándor János
P356
10.1007/978-90-481-9485-8_2
P407
P577
2010-01-01T00:00:00Z